Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective NR2B antagonists

Selective NR2B antagonists

US Patent 8722670 · Granted May 13, 2014

Estimated economic value: $132,549,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinazolinyl compounds useful as T cell activators2025
Heterocyclic PAD4 inhibitors2025
Substituted piperazine derivatives useful as T cell activators2025
Methods for treatment of diseases involving acidic or hypoxic diseased tissues2025
Antisense oligonucleotides targeting alpha-synuclein and uses thereof2025
Antisense oligonucleotides targeting alpha-synuclein and uses thereof2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
Oligonucleotides for modulating Tau expression2024
Aminotriazolopyridines as kinase inhibitors2024
Indazole carboxamides as kinase inhibitors2024
Phosphorus (V)-based reagents, processes for the preparation thereof, and their 2024
Biaryl kinase inhibitors2024